VIBRACONNECT vs Kribado

Most of the 400+ million diabetic patients in the world may be unaware of the looming threat of foot ulcers leading to amputation. High glucose in the blood can lead to neuropathy - damage of nerve cells and loss of sensation, especially on the foot. Hidden injuries are not felt, do not heal, become ulcers, and if untreated lead to gangrene and require amputations - ranging from toe to entire leg. Every 30 seconds, there is one patient who loses his limb because of diabetes. There are an estimated 2 lakh diabetic foot amputations in India every year, leading to disability and further aggravation of the diabetic condition. This can be prevented by early screening for neuropathy. Ayati has come up with VIBRASENSE, a diabetic foot screener on which patients will place the foot and the report will be generated in 50% less time compared to current solutions. VIBRACONNECT application is developed to support VIBRASENSE for generating and sharing the reports. It also enables monitoring the diabetic patients, if they are progressing towards neuropathy. Disclaimer: 1) The usage of the application is restricted to those locations where VIBRASENSE has regulatory clearance. 2) Users to seek a doctor's advice in addition to using this app before making any medical decisions.

The Kribado is the next generation risk stratification and behaviour setting device for Healthcare Practitioners (HCP) and Healthcare companies. A non-invasive screening protocol that instantly provides a risk score for a patient in the waiting room, making it possible to triage these patients to the relevant areas/procedures by early identification of risk. It is designed to eliminate data collection errors by structuring each screen so that it is easy to use with consistent data. The Kribado will assist physicians in treating patients by implementing a pre-admission risk strat. Kribado consists of a small touch-screen connected to a embeded printer, and operates using AI and risk scoring algorithms trained on perfect human data. The end result is that it helps alert the healthcare professionals to potential behavioral risk factors of each patient in waiting areas. It also gives each company an accurate overview of their surveys, phase IV studies and in-clinic camps.